161 related articles for article (PubMed ID: 32257207)
61. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
Liu T; Wang N; Cao J; Sofiadis A; Dinets A; Zedenius J; Larsson C; Xu D
Oncogene; 2014 Oct; 33(42):4978-84. PubMed ID: 24141777
[TBL] [Abstract][Full Text] [Related]
62. Association of newly identified genetic variant rs2853677 of TERT with non-small cell lung cancer and leukemia in population of Jammu and Kashmir, India.
Bhat GR; Bhat A; Verma S; Sethi I; Shah R; Sharma V; Dar KA; Abrol D; Kaneez S; Kaul S; Ganju R; Kumar R
BMC Cancer; 2019 May; 19(1):493. PubMed ID: 31126249
[TBL] [Abstract][Full Text] [Related]
63. Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma.
Pezzuto F; Izzo F; Buonaguro L; Annunziata C; Tatangelo F; Botti G; Buonaguro FM; Tornesello ML
Oncotarget; 2016 Aug; 7(34):54253-54262. PubMed ID: 27276713
[TBL] [Abstract][Full Text] [Related]
64. Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.
Shi X; Liu R; Qu S; Zhu G; Bishop J; Liu X; Sun H; Shan Z; Wang E; Luo Y; Yang X; Zhao J; Du J; El-Naggar AK; Teng W; Xing M
J Clin Endocrinol Metab; 2015 Apr; 100(4):E632-7. PubMed ID: 25584719
[TBL] [Abstract][Full Text] [Related]
65. The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women.
Govan VA; Constant D; Hoffman M; Williamson AL
BMC Cancer; 2006 Jan; 6():24. PubMed ID: 16438713
[TBL] [Abstract][Full Text] [Related]
66. Association of TERT-CLPTM1L and 8q24 Common Genetic Variants with Gallbladder Cancer Susceptibility and Prognosis in North Indian Population.
Yadav S; Chandra A; Kumar A; Mittal B
Biochem Genet; 2018 Aug; 56(4):267-282. PubMed ID: 29450669
[TBL] [Abstract][Full Text] [Related]
67. Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.
Thiem S; Herold T; Krafft U; Bremmer F; Tolkach Y; Szász AM; Kriegsmann J; Gaisa NT; Niedworok C; Szarvas T; Reis H
Pathol Int; 2017 Dec; 67(12):597-601. PubMed ID: 29047227
[TBL] [Abstract][Full Text] [Related]
68. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
Qasem E; Murugan AK; Al-Hindi H; Xing M; Almohanna M; Alswailem M; Alzahrani AS
Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077
[TBL] [Abstract][Full Text] [Related]
69. Effects of Coexistent BRAF
Moon S; Song YS; Kim YA; Lim JA; Cho SW; Moon JH; Hahn S; Park DJ; Park YJ
Thyroid; 2017 May; 27(5):651-660. PubMed ID: 28181854
[TBL] [Abstract][Full Text] [Related]
70. TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
Gao K; Li G; Qu Y; Wang M; Cui B; Ji M; Shi B; Hou P
Oncotarget; 2016 Feb; 7(8):8712-25. PubMed ID: 26556853
[TBL] [Abstract][Full Text] [Related]
71. Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma.
Jeon MJ; Kim WG; Sim S; Lim S; Kwon H; Kim TY; Shong YK; Kim WB
Endocrinol Metab (Seoul); 2016 Mar; 31(1):100-4. PubMed ID: 26676331
[TBL] [Abstract][Full Text] [Related]
72. Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma.
Chang KP; Wang CI; Pickering CR; Huang Y; Tsai CN; Tsang NM; Kao HK; Cheng MH; Myers JN
Head Neck; 2017 Jun; 39(6):1131-1137. PubMed ID: 28230921
[TBL] [Abstract][Full Text] [Related]
73. TERT promoter mutations in primary and secondary glioblastomas.
Nonoguchi N; Ohta T; Oh JE; Kim YH; Kleihues P; Ohgaki H
Acta Neuropathol; 2013 Dec; 126(6):931-7. PubMed ID: 23955565
[TBL] [Abstract][Full Text] [Related]
74. Clinicopathological significance of TERT promoter mutation in papillary thyroid carcinomas: a systematic review and meta-analysis.
Yin DT; Yu K; Lu RQ; Li X; Xu J; Lei M; Li H; Wang Y; Liu Z
Clin Endocrinol (Oxf); 2016 Aug; 85(2):299-305. PubMed ID: 26732020
[TBL] [Abstract][Full Text] [Related]
75. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.
Nguyen D; Taheri D; Springer S; Cowan M; Guner G; Mendoza Rodriguez MA; Wang Y; Kinde I; VandenBussche CJ; Olson MT; Ricardo BF; Cunha I; Fujita K; Ertoy D; Kinzler KW; Bivalacqua TJ; Papadopoulos N; Vogelstein B; Netto GJ
Virchows Arch; 2016 Oct; 469(4):427-34. PubMed ID: 27520411
[TBL] [Abstract][Full Text] [Related]
76. The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection.
Singh N; Hussain S; Sharma U; Suri V; Nijhawan R; Bharadwaj M; Sobti RC
Tumour Biol; 2016 Apr; 37(4):5295-303. PubMed ID: 26561467
[TBL] [Abstract][Full Text] [Related]
77. Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis.
Yuan P; Cao JL; Abuduwufuer A; Wang LM; Yuan XS; Lv W; Hu J
PLoS One; 2016; 11(1):e0146803. PubMed ID: 26799744
[TBL] [Abstract][Full Text] [Related]
78.
Saito T; Akaike K; Kurisaki-Arakawa A; Toda-Ishii M; Mukaihara K; Suehara Y; Takagi T; Kaneko K; Yao T
Mol Clin Oncol; 2016 Jan; 4(1):61-64. PubMed ID: 26870359
[TBL] [Abstract][Full Text] [Related]
79. Identification of h-TERT Promoter Mutations in Germline DNA from North Indian Lung Carcinoma Patients.
Prasad R; Panchal S; Rani I; Kishan J; Parashar G
Indian J Clin Biochem; 2023 Jan; 38(1):120-127. PubMed ID: 36684496
[TBL] [Abstract][Full Text] [Related]
80. Pan-cancer experimental characteristic of human transcriptional patterns connected with telomerase reverse transcriptase (
Drobyshev A; Modestov A; Suntsova M; Poddubskaya E; Seryakov A; Moisseev A; Sorokin M; Tkachev V; Zakharova G; Simonov A; Zolotovskaia MA; Buzdin A
Front Genet; 2024; 15():1401100. PubMed ID: 38859942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
